Aoyuan Healthy acquires 55% equity in Liantianmei for $101.72m | Health Care Asia Magazine - The Latest News, Headlines, Insight, Commentary & Analysis

Aoyuan Healthy acquires 55% equity in Liantianmei for $101.72m

With this acquisition, Aoyuan holds 60% equity interest in the company.

Aoyuan Healthy Life Group Company (Aoyuan Healthy) has agreed to acquire a 55% equity interest in Zhejiang Liantianmei Corporate Management Company (Liantianmei) through its indirect wholly-owned subsidiary Guangdong Xinyuerong Industrial Investment Company, for a total consideration of $101.72m, the group has revealed in a press release.

The consideration for the acquisition will be paid and funded by a combination of the unutilized net proceeds, group's internal resources and bank borrowings.

The group has also decided to reallocate the proceeds from its global offering for the purposes of its business development. Approximately $19.49m of the unutilized net proceeds will be used for acquisition or investment in other commercial operational and property management service providers, and $31.65m of the proceeds for the acquisition or investment in service providers providing services complementary to the group's services.

Get Health Care Asia Magazine in your inbox
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

The majority of the country’s pharma manufacturing produces generic drugs.
This is expected to affect local pharma growth in the short term.
Nonetheless, more than half of the age group found its use to be comfortable.
The group’s profits after tax ballooned by as much as 138.4%.
Funds will be used to build out its behavioural health and chronic care modules.
Some players have been highly active in digital channels of various countries.
It has also formed a JV with Acurio to develop a private hospital in NSW.
With this, the company now offers an all-in-one patient management service.
The therapy can be done in eight different languages.
The country is expected to have one in five of its population to be elderly by 2050.
Sunway is planning to ramp up its hospital capacity to about 3,000 beds.
The system will help city managers to track epidemic conditions, real-time.
It is funded through the 2020 Primary Healthcare Research Data Infrastructure grants.
The hospital features 200 general inpatient beds and 100 hemodialysis beds.
The platform expanded its services after obtaining an internet hospital license.